Viewing Study NCT04920760



Ignite Creation Date: 2024-05-06 @ 4:15 PM
Last Modification Date: 2024-10-26 @ 2:06 PM
Study NCT ID: NCT04920760
Status: UNKNOWN
Last Update Posted: 2021-06-18
First Post: 2021-06-09

Brief Title: Vitamin A Supplementation in Children With Moderate to Severe COVID-19
Sponsor: Shiraz University of Medical Sciences
Organization: Shiraz University of Medical Sciences

Study Overview

Official Title: The Effect of Vitamin A Supplementation on Disease Improvement of Children With Moderate to Severe COVID-19
Status: UNKNOWN
Status Verified Date: 2021-06
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Severe acute respiratory syndrome SARS-like coronavirus 2 Sars-CoV-2 pandemia is considered to be the current major global health issue With no specific treatment or vaccine known to be licensed empowering the immune system to overcome the inflammatory status associated with the late stages of the disease particularly by anti-inflammatory nutrients is of great concern

Effective in reducing both the morbidity and mortality of respiratory infections including measles vitamin A and its derivatives are reported to enhance the immune system andor antibody response to virus vaccinations in children particularly those with vitamin insufficiency Retinoids are therefore proposed as an adjunct therapy in the treatment of COVID-19 The study is aimed to investigate the effects of vitamin A supplementation on disease improvement in pediatric and adolescent patients with either moderate or severe COVID-19 disease
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None